Innovating Works

Muscle stress relief

Financiado
Muscle Stress Relief An integrated research program linking together basic rese...
Muscle Stress Relief An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology. A diverse variety of medical or lifestyle conditions lead to a progressive loss of muscle force by functionally impairing myofibril contractility and causing ultimately myofibril loss. Major underlying risk factors of chronic musc... A diverse variety of medical or lifestyle conditions lead to a progressive loss of muscle force by functionally impairing myofibril contractility and causing ultimately myofibril loss. Major underlying risk factors of chronic muscle force loss are ageing, inactive lifestyles, and unbalanced nutrition. Together, these factors are predicted to lead to an endemic incidence of muscle weakness both in the developed countries. Clinical research on the mechanisms involved requires a multidisciplinary approach covering aspects of ageing, metabolism, and on the humoral cross-talk of muscle with other key organs including heart, liver, kidney, and lung. To achieve this, six European groups with complementary expertise in inter-organ-cross-talk during stress-induced secondary myopathies will team-up with three leading teams in the U.S. with expertise in myopathy animal models, myofilament proteins and translation of muscle research into therapeutic interventions, and with one team from South Africa with cutting-edge expertise in the regulation of regenerative capacities in muscle. Importantly, five SMEs will participate in this RISE network that provide expertise in early muscle disease detection, monitoring, and the developing preventive strategies: Their knowledge on muscle disease detection at early stages and their monitoring during interventions will promote translational innovation. To implement innovation and our joint research program, both early stage and advanced researchers will be seconded from the academic nine teams to these five SMEs and vice versa. Thereby, this RISE scheme will establish a long-term collaborative University-SME driven translational innovative research program innovation in our interdisciplinary field of growing socioeconomic medical importance. ver más
29/02/2020
UNIVERSITY OF THES...
2M€
Duración del proyecto: 62 meses Fecha Inicio: 2014-12-03
Fecha Fin: 2020-02-29

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2020-02-29
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
MSCA-RISE-2014: Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)
Cerrada hace 10 años
Presupuesto El presupuesto total del proyecto asciende a 2M€
Líder del proyecto
PANEPISTIMIO THESSALIAS No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5